Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Facial cranial nerve disorders
ADR ID BADD_A01599
ADR Hierarchy
17      Nervous system disorders
17.04      Cranial nerve disorders (excl neoplasms)
17.04.03      Facial cranial nerve disorders
Description Not Available
MedDRA Code 10016054
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01378Memantine0.000121%
BADD_D01397Mesalamine0.000183%
BADD_D01418Methotrexate--
BADD_D01425Methyldopa--
BADD_D01426Methyldopate hydrochloride--
BADD_D01431Methylphenidate0.000082%
BADD_D01442Metoclopramide0.000784%
BADD_D01449Metronidazole0.000171%
BADD_D01470Minocycline0.000236%
BADD_D01476Mirtazapine--
BADD_D01484Modafinil--
BADD_D01491Mometasone furoate--
BADD_D01496Montelukast--
BADD_D01501Moxifloxacin--
BADD_D01502Moxifloxacin hydrochloride--
BADD_D01508Mycophenolic acid0.001427%
BADD_D01533Naproxen--
BADD_D01546Nefazodone--
BADD_D01547Nefazodone hydrochloride--
BADD_D01564Nicotine0.000627%
BADD_D01567Nilotinib0.002339%
BADD_D01579Nitroglycerin--
BADD_D01588Nortriptyline--
BADD_D01595Octreotide acetate--
BADD_D01598Ofloxacin--
BADD_D01599Olanzapine0.002000%
BADD_D01611Omega-3-acid ethyl esters--
BADD_D01616Onabotulinumtoxina--
BADD_D01621Optimark--
BADD_D01629Osimertinib0.000280%
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 9 Pages